Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-025070
Filing Date
2021-06-21
Accepted
2021-06-21 18:20:58
Documents
1
Period of Report
2021-06-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7101
  Complete submission text file 0000899243-21-025070.txt   8415
Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 (978) 501-3026
Verve Therapeutics, Inc. (Issuer) CIK: 0001840574 (see all company filings)

EIN.: 824800132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 500 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
Kathiresan Sekar (Reporting) CIK: 0001864112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40489 | Film No.: 211032399